Anne DeGheest
Founder & Managing director @ HealthTech Capital
San Francisco, United States
Anne DeGheest is a mentor capitalist specializing in investing and mentoring early-stage start-ups in healthcare. She founded MedStars Ventures Partners and HealthTech Capital, a new ecosystem between private angel investors, venture capitalists and industry players to fund and mentor new "HealthTech" companies that decrease healthcarecost by leveraging computer and mobility technology. The life science companies for which she has been a founder or an early advisor have generated over $6 billion in market capitalization including Pyxis (now part of CareFusion), Aspect Medical (acquired by Covidien), VISX (acquired by AMO), Thermage (merged into Solta Medical), VISICU(acquired by Philips), Masimo (Nasdaq: MASI), Nellcor (a division of Covidien), MedPool and OmniCell (Nasdaq: OMCL).She has an MBA from Harvard and a Master in Business Engineering from University of Brussels.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Anne DeGheest invests in
Stages Anne DeGheest invests in
Countries Anne DeGheest invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (100%)
- Hospital 1 (50%)
- Software 1 (50%)
- Wearables 1 (50%)
- Medical Device 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Bloomlife is an award winning women’s health company solving the most significant yet underserved global challenges today in maternal health. We are redefining the way maternal care is delivered by combining connected devices with cloud based data analytics to improve access to care, empower women, and provide clinicians with information to moreeffectively screen and manage pregnancy complications. Our goal is to become the leading provider of remote care for expectant women globally. Bloomlife’s approach to managing high risk pregnancies allows obstetricians to more easily screen maternal and fetal risk, educate the patient, and quickly access high risk specialists regardless of a patient’s geography. Our solution represents a marked shift from the way high risk pregnancies have been historically assessed using frequent in person appointments, paper logs, and long referral times. | $5.5M / Seed / Aug 15, 2016 | ||
| At CareinSync, their mission is to significantly improve patient care quality & efficiency by enhancing communication across care providers & patients over a real-time, mobile, collaboration platform. | $1.6M / Series A / Jun 06, 2012 |
Co-Investors
About HealthTech Capital
HealthTech Capital is a group of private investors dedicated to funding and mentoring new "HealthTech" start ups at the intersection of healthcare with the computer and mobility worlds. HealthTech Capital is creating a new ecosystem with leading edge clinical providers, venture firms and other strategic industry players.
HealthTech Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anne DeGheest
Founder & Managing director
|
|||
Carl Bouthillette
Investor, Member, and Screening Committee Chair
|
|||
Laura Fay
Founding Member
|
|||
Rose Ann Haft
Analyst in Residence
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Anne DeGheest invest in?
Anne DeGheest invests primarily in Health Care, Hospital and Software startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Anne DeGheest?
Public channels for Anne DeGheest include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Anne DeGheest last invest?
The most recent investment recorded for Anne DeGheest closed in Aug 2016. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
